Analytical Data
-
基因名
D21S2056E
- Application
-
别名
D21S2056E; NNP 1; NNP-1; NNP1; Nnp1 homolog nucleolar protein; NOP52; Novel nuclear protein 1; Nucleolar protein Nop52; Nucleolar protein. 52-KD; Protein NNP 1; Protein NNP1; Ribosomal RNA processing 1; Ribosomal RNA processing 1 homolog
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P56182
-
表达区间
1-461aa
-
氨基酸序列
MVSRVQLPPEIQLAQRLAGNEQVTRDRAVRKLRKYIVARTQRAAGGFTHDELLKVWKGLFYCMWMQDKPLLQEELGRTISQLVHAFQTTEAQHLFLQAFWQTMNREWTGIDRLRLDKFYMLMRMVLNESLKVLKMQGWEERQIEELLELLMTEILHPSSQAPNGVKSHFIEIFLEELTKVGAEELTADQNLKFIDPFCRIAARTKDSLVLNNITRGIFETIVEQAPLAIEDLLNELDTQDEEVASDSDESSEGGERGDALSQKRSEKPPAGSICRAEPEAGEEQAGDDRDSGGPVLQFDYEAVANRLFEMASRQSTPSQNRKRLYKVIRKLQDLAGGIFPEDEIPEKACRRLLEGRRQKKTKKQKRLLRLQQERGKGEKEPPSPGMERKRSRRRGVGADPEARAEAGEQPGTAERALLRDQPRGRGQRGARQRRRTPRPLTSARAKAANVQEPEKKKKRRE
-
分子量
76.45 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
D21S2056E, a recombinant protein, has garnered significant attention in the fields of molecular biology and genetics due to its unique characteristics and potential applications. This protein is derived from the D21S2056 locus, which is involved in various biological processes, including cell signaling, development, and disease mechanisms. The study of D21S2056E is crucial for understanding its role in genetic disorders and its implications in therapeutic developments. By utilizing recombinant DNA technology, researchers can produce this protein in a controlled manner, allowing for in-depth analysis of its structure and function. Furthermore, investigating D21S2056E can provide insights into protein-protein interactions, post-translational modifications, and its possible involvement in oncogenesis. The enhanced availability of D21S2056E through recombinant methods paves the way for high-throughput screening in drug discovery and the development of targeted therapies. Overall, the exploration of D21S2056E not only enriches our comprehension of fundamental biological processes but also holds promise for innovative clinical applications in the management of genetic diseases and cancer.
